The Enterprise Value as of October 2024 (TTM) for InVivo Therapeutics Holdings Corp. (NVIV) is -7585082.00

According to InVivo Therapeutics Holdings Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -7585082.00. This represents a change of -5.37% compared to the average of -8015915.44 of the last 4 quarters.

InVivo Therapeutics Holdings Corp. (NVIV) Historical Enterprise Value (quarterly & annually)

How has NVIV Enterprise Value performed in the past?

The mean historical Enterprise Value of InVivo Therapeutics Holdings Corp. over the last ten years is 53.02M. The current -7585082.00 Enterprise Value has changed -1530.55% with respect to the historical average. Over the past ten years (40 quarters), NVIV's Enterprise Value was at its highest in in the June 2015 quarter at 404.62M. The Enterprise Value was at its lowest in in the June 2018 quarter at -19051125.00.

InVivo Therapeutics Holdings Corp. (NVIV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of InVivo Therapeutics Holdings Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InVivo Therapeutics Holdings Corp. (NVIV) Average Enterprise Value

How has NVIV Enterprise Value performed in the past?

The current Enterprise Value of InVivo Therapeutics Holdings Corp. (NVIV) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

InVivo Therapeutics Holdings Corp. (NVIV) Enterprise Value vs. Peers

How is NVIV’s Enterprise Value compared to its peers?

InVivo Therapeutics Holdings Corp.’s Enterprise Value is less than Virax Biolabs Group Limited (3.41M), less than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-8879083.00), less than Hillstream BioPharma, Inc. (1.48M), less than Kiora Pharmaceuticals, Inc. (3.34M), less than NextCure, Inc. (25.87M), less than CytomX Therapeutics, Inc. (59.12M), less than Neoleukin Therapeutics, Inc. (-6333315.00), less than Spero Therapeutics, Inc. (10.86M), less than Assembly Biosciences, Inc. (97.39M), less than Nutriband Inc. (72.31M), less than Quoin Pharmaceuticals, Ltd. (3.01M), less than Longeveron Inc. (21.11M), less than RenovoRx, Inc. (12.24M), less than Anebulo Pharmaceuticals, Inc. (44.36M), less than Rezolute, Inc. (196.93M), less than HCW Biologics Inc. (30.04M), less than Eliem Therapeutics, Inc. (119.64M), greater than Molecular Partners AG (-13021083.75), less than Senti Biosciences, Inc. (29.73M), less than SAB Biotherapeutics, Inc. (13.57M),

Build a custom stock screener for InVivo Therapeutics Holdings Corp. (NVIV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InVivo Therapeutics Holdings Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InVivo Therapeutics Holdings Corp. (NVIV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InVivo Therapeutics Holdings Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.